Anti-vaccine sentiment may derail vaccines already awaiting FDA approval, experts fear

RFK Jr. suggests some vaccines are risky or ineffective, downplays measles threat

The comments, dismissed by health experts, come as the HHS secretary faces a growing outbreak of measles that could test his leadership.

Voices: As LDS women of faith, we’re distressed by pullback from vaccines. You should be, too.

“Our greatness is not measured by how fiercely we protect our own but by how faithfully we care for our neighbors in our global community,” write Emma Petty Addams and Jill Fairholm with Mormon Women for Ethical Government.

FDA Delays Ful Approval of Novavax COVID Vaccine

An FDA decision on full approval of the Novavax COVID-19 vaccine was expected by April 1, but the agency now says it needs more information before moving forward.

FDA Delays Final Approval of Novavax COVID Vaccine

Key Takeaways

The U.S. drug regulator failed to meet the deadline for granting full approval to Novavax’s covid-19 vaccine, the company reported Wednesday, amid major changes in health agencies under President Donald Trump’s mandate. In a document sent to the financial market regulator and viewed by the AFP, the U.S. drug manufacturer Novavax said he was still awaiting a response from the Food and Drug Administration (FDA), which had promised to make a decisi…

Approval Of COVID-19 Jab Delayed

The U.S. Food and Drug Administration (FDA) has delayed granting full approval of Novavax’s COVID-19 jab. According to POLITICO, a top FDA official “directly intervened” in an agency review. Inching very slowly towards the finish line. pic.twitter.com/HT4g202FPX — Mary Talley Bowden MD (@MdBreathe) April 3, 2025 From POLITICO: Dr. Sara Brenner, FDA’s Principal Deputy Commissioner, took the highly unusual step, cutting against longstanding prec…